MAPT and Alzheimer disease: Since tauopathy is a key process that is triggered following TBI in the AD brain, confirmed both biochemically and histopathologically, we demonstrate, for the first time, the potential of DTI to map the spatial and temporal profile of the pathological processes following TBI in a tau transgenic mouse model.